Review



opg  (Proteintech)


Bioz Verified Symbol Proteintech is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 94
      Buy from Supplier

    Structured Review

    Proteintech opg
    COL-I, OCN, <t>OPG</t> and RANKL protein expression levels in each group after 8 weeks of intervention. (A) COL-I, OCN, OPG and RANKL protein expression level of each treatment group. Average optical density of (B) COL-I, (C) OCN, (D) OPG and (E) RANKL in each group. *P<0.05 vs. Ctrl group; # P<0.05 vs. T2DM model group. COL-I, type I collagen; <t>OCN,</t> <t>osteocalcin;</t> OPG, osteoprotegerin; RANKL, receptor activator of nuclear factor-κB ligand; Ctrl, control; T2DM, type 2 diabetes mellitus; ZnC, zinc carnosine; AOD, average optical density value.
    Opg, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 9 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/opg/product/Proteintech
    Average 94 stars, based on 9 article reviews
    opg - by Bioz Stars, 2026-05
    94/100 stars

    Images

    1) Product Images from "Effects of zinc carnosine on bone loss in mice with diabetic osteoporosis"

    Article Title: Effects of zinc carnosine on bone loss in mice with diabetic osteoporosis

    Journal: Molecular Medicine Reports

    doi: 10.3892/mmr.2025.13723

    COL-I, OCN, OPG and RANKL protein expression levels in each group after 8 weeks of intervention. (A) COL-I, OCN, OPG and RANKL protein expression level of each treatment group. Average optical density of (B) COL-I, (C) OCN, (D) OPG and (E) RANKL in each group. *P<0.05 vs. Ctrl group; # P<0.05 vs. T2DM model group. COL-I, type I collagen; OCN, osteocalcin; OPG, osteoprotegerin; RANKL, receptor activator of nuclear factor-κB ligand; Ctrl, control; T2DM, type 2 diabetes mellitus; ZnC, zinc carnosine; AOD, average optical density value.
    Figure Legend Snippet: COL-I, OCN, OPG and RANKL protein expression levels in each group after 8 weeks of intervention. (A) COL-I, OCN, OPG and RANKL protein expression level of each treatment group. Average optical density of (B) COL-I, (C) OCN, (D) OPG and (E) RANKL in each group. *P<0.05 vs. Ctrl group; # P<0.05 vs. T2DM model group. COL-I, type I collagen; OCN, osteocalcin; OPG, osteoprotegerin; RANKL, receptor activator of nuclear factor-κB ligand; Ctrl, control; T2DM, type 2 diabetes mellitus; ZnC, zinc carnosine; AOD, average optical density value.

    Techniques Used: Expressing, Control

    mRNA expression levels of bone metabolism-related factors. *P<0.05 and ***P<0.01 vs. Ctrl group; ## P<0.01 vs. T2DM model group. (A) Ctrl, control; (B) T2DM, type 2 diabetes mellitus; (C) ZnC, zinc carnosine. OCN, osteocalcin; OPG, osteoprotegerin; RANKL, receptor activator of nuclear factor-κB ligand.
    Figure Legend Snippet: mRNA expression levels of bone metabolism-related factors. *P<0.05 and ***P<0.01 vs. Ctrl group; ## P<0.01 vs. T2DM model group. (A) Ctrl, control; (B) T2DM, type 2 diabetes mellitus; (C) ZnC, zinc carnosine. OCN, osteocalcin; OPG, osteoprotegerin; RANKL, receptor activator of nuclear factor-κB ligand.

    Techniques Used: Expressing, Control



    Similar Products

    anti mouse rankl monoclonal antibody  (Bio X Cell)
    98
    Bio X Cell anti mouse rankl monoclonal antibody
    Anti Mouse Rankl Monoclonal Antibody, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti mouse rankl monoclonal antibody/product/Bio X Cell
    Average 98 stars, based on 1 article reviews
    anti mouse rankl monoclonal antibody - by Bioz Stars, 2026-05
    98/100 stars
    		  Buy from Supplier
    mouse rankl monoclonal antibody  (Novus Biologicals)
    93
    Novus Biologicals mouse rankl monoclonal antibody
    Mouse Rankl Monoclonal Antibody, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse rankl monoclonal antibody/product/Novus Biologicals
    Average 93 stars, based on 1 article reviews
    mouse rankl monoclonal antibody - by Bioz Stars, 2026-05
    93/100 stars
    		  Buy from Supplier
    opg  (Proteintech)
    94
    Proteintech opg
    COL-I, OCN, <t>OPG</t> and RANKL protein expression levels in each group after 8 weeks of intervention. (A) COL-I, OCN, OPG and RANKL protein expression level of each treatment group. Average optical density of (B) COL-I, (C) OCN, (D) OPG and (E) RANKL in each group. *P<0.05 vs. Ctrl group; # P<0.05 vs. T2DM model group. COL-I, type I collagen; <t>OCN,</t> <t>osteocalcin;</t> OPG, osteoprotegerin; RANKL, receptor activator of nuclear factor-κB ligand; Ctrl, control; T2DM, type 2 diabetes mellitus; ZnC, zinc carnosine; AOD, average optical density value.
    Opg, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/opg/product/Proteintech
    Average 94 stars, based on 1 article reviews
    opg - by Bioz Stars, 2026-05
    94/100 stars
    		  Buy from Supplier
    mouse anti rankl  (Proteintech)
    95
    Proteintech mouse anti rankl
    COL-I, OCN, <t>OPG</t> and RANKL protein expression levels in each group after 8 weeks of intervention. (A) COL-I, OCN, OPG and RANKL protein expression level of each treatment group. Average optical density of (B) COL-I, (C) OCN, (D) OPG and (E) RANKL in each group. *P<0.05 vs. Ctrl group; # P<0.05 vs. T2DM model group. COL-I, type I collagen; <t>OCN,</t> <t>osteocalcin;</t> OPG, osteoprotegerin; RANKL, receptor activator of nuclear factor-κB ligand; Ctrl, control; T2DM, type 2 diabetes mellitus; ZnC, zinc carnosine; AOD, average optical density value.
    Mouse Anti Rankl, supplied by Proteintech, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse anti rankl/product/Proteintech
    Average 95 stars, based on 1 article reviews
    mouse anti rankl - by Bioz Stars, 2026-05
    95/100 stars
    		  Buy from Supplier
    anti mouse rankl monoclonal antibody  (Oriental Yeast Co)
    86
    Oriental Yeast Co anti mouse rankl monoclonal antibody
    COL-I, OCN, <t>OPG</t> and RANKL protein expression levels in each group after 8 weeks of intervention. (A) COL-I, OCN, OPG and RANKL protein expression level of each treatment group. Average optical density of (B) COL-I, (C) OCN, (D) OPG and (E) RANKL in each group. *P<0.05 vs. Ctrl group; # P<0.05 vs. T2DM model group. COL-I, type I collagen; <t>OCN,</t> <t>osteocalcin;</t> OPG, osteoprotegerin; RANKL, receptor activator of nuclear factor-κB ligand; Ctrl, control; T2DM, type 2 diabetes mellitus; ZnC, zinc carnosine; AOD, average optical density value.
    Anti Mouse Rankl Monoclonal Antibody, supplied by Oriental Yeast Co, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti mouse rankl monoclonal antibody/product/Oriental Yeast Co
    Average 86 stars, based on 1 article reviews
    anti mouse rankl monoclonal antibody - by Bioz Stars, 2026-05
    86/100 stars
    		  Buy from Supplier
    invivomab anti mouse rankl cd254 clone ik22 5  (Bio X Cell)
    93
    Bio X Cell invivomab anti mouse rankl cd254 clone ik22 5
    COL-I, OCN, <t>OPG</t> and RANKL protein expression levels in each group after 8 weeks of intervention. (A) COL-I, OCN, OPG and RANKL protein expression level of each treatment group. Average optical density of (B) COL-I, (C) OCN, (D) OPG and (E) RANKL in each group. *P<0.05 vs. Ctrl group; # P<0.05 vs. T2DM model group. COL-I, type I collagen; <t>OCN,</t> <t>osteocalcin;</t> OPG, osteoprotegerin; RANKL, receptor activator of nuclear factor-κB ligand; Ctrl, control; T2DM, type 2 diabetes mellitus; ZnC, zinc carnosine; AOD, average optical density value.
    Invivomab Anti Mouse Rankl Cd254 Clone Ik22 5, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/invivomab anti mouse rankl cd254 clone ik22 5/product/Bio X Cell
    Average 93 stars, based on 1 article reviews
    invivomab anti mouse rankl cd254 clone ik22 5 - by Bioz Stars, 2026-05
    93/100 stars
    		  Buy from Supplier
    srsltid afmboorha0a2pil0pxigisxdwvcuzytjl02cmdyeqtb6edzaadsxl7sf mouse mab anti rankl  (Santa Cruz Biotechnology)
    96
    Santa Cruz Biotechnology srsltid afmboorha0a2pil0pxigisxdwvcuzytjl02cmdyeqtb6edzaadsxl7sf mouse mab anti rankl
    COL-I, OCN, <t>OPG</t> and RANKL protein expression levels in each group after 8 weeks of intervention. (A) COL-I, OCN, OPG and RANKL protein expression level of each treatment group. Average optical density of (B) COL-I, (C) OCN, (D) OPG and (E) RANKL in each group. *P<0.05 vs. Ctrl group; # P<0.05 vs. T2DM model group. COL-I, type I collagen; <t>OCN,</t> <t>osteocalcin;</t> OPG, osteoprotegerin; RANKL, receptor activator of nuclear factor-κB ligand; Ctrl, control; T2DM, type 2 diabetes mellitus; ZnC, zinc carnosine; AOD, average optical density value.
    Srsltid Afmboorha0a2pil0pxigisxdwvcuzytjl02cmdyeqtb6edzaadsxl7sf Mouse Mab Anti Rankl, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/srsltid afmboorha0a2pil0pxigisxdwvcuzytjl02cmdyeqtb6edzaadsxl7sf mouse mab anti rankl/product/Santa Cruz Biotechnology
    Average 96 stars, based on 1 article reviews
    srsltid afmboorha0a2pil0pxigisxdwvcuzytjl02cmdyeqtb6edzaadsxl7sf mouse mab anti rankl - by Bioz Stars, 2026-05
    96/100 stars
    		  Buy from Supplier

    Image Search Results


    COL-I, OCN, OPG and RANKL protein expression levels in each group after 8 weeks of intervention. (A) COL-I, OCN, OPG and RANKL protein expression level of each treatment group. Average optical density of (B) COL-I, (C) OCN, (D) OPG and (E) RANKL in each group. *P<0.05 vs. Ctrl group; # P<0.05 vs. T2DM model group. COL-I, type I collagen; OCN, osteocalcin; OPG, osteoprotegerin; RANKL, receptor activator of nuclear factor-κB ligand; Ctrl, control; T2DM, type 2 diabetes mellitus; ZnC, zinc carnosine; AOD, average optical density value.

    Journal: Molecular Medicine Reports

    Article Title: Effects of zinc carnosine on bone loss in mice with diabetic osteoporosis

    doi: 10.3892/mmr.2025.13723

    Figure Lengend Snippet: COL-I, OCN, OPG and RANKL protein expression levels in each group after 8 weeks of intervention. (A) COL-I, OCN, OPG and RANKL protein expression level of each treatment group. Average optical density of (B) COL-I, (C) OCN, (D) OPG and (E) RANKL in each group. *P<0.05 vs. Ctrl group; # P<0.05 vs. T2DM model group. COL-I, type I collagen; OCN, osteocalcin; OPG, osteoprotegerin; RANKL, receptor activator of nuclear factor-κB ligand; Ctrl, control; T2DM, type 2 diabetes mellitus; ZnC, zinc carnosine; AOD, average optical density value.

    Article Snippet: The primary antibodies used and their dilution ratios are as follows: Type I collagen (COL-I; 1:200; cat. no. AF7001; Affinity Biosciences), osteocalcin (OCN, 1:200; cat. no. 16157-1-AP; Proteintech Group, Inc.) and OPG (1:200; cat. no 31766-1-AP; Proteintech Group, Inc.).

    Techniques: Expressing, Control

    mRNA expression levels of bone metabolism-related factors. *P<0.05 and ***P<0.01 vs. Ctrl group; ## P<0.01 vs. T2DM model group. (A) Ctrl, control; (B) T2DM, type 2 diabetes mellitus; (C) ZnC, zinc carnosine. OCN, osteocalcin; OPG, osteoprotegerin; RANKL, receptor activator of nuclear factor-κB ligand.

    Journal: Molecular Medicine Reports

    Article Title: Effects of zinc carnosine on bone loss in mice with diabetic osteoporosis

    doi: 10.3892/mmr.2025.13723

    Figure Lengend Snippet: mRNA expression levels of bone metabolism-related factors. *P<0.05 and ***P<0.01 vs. Ctrl group; ## P<0.01 vs. T2DM model group. (A) Ctrl, control; (B) T2DM, type 2 diabetes mellitus; (C) ZnC, zinc carnosine. OCN, osteocalcin; OPG, osteoprotegerin; RANKL, receptor activator of nuclear factor-κB ligand.

    Article Snippet: The primary antibodies used and their dilution ratios are as follows: Type I collagen (COL-I; 1:200; cat. no. AF7001; Affinity Biosciences), osteocalcin (OCN, 1:200; cat. no. 16157-1-AP; Proteintech Group, Inc.) and OPG (1:200; cat. no 31766-1-AP; Proteintech Group, Inc.).

    Techniques: Expressing, Control